课题基金 / 基金详情

Methylphenidate-primed rTMS for apathy in neurocognitive disorders

Methylphenidate-primed rTMS for apathy in neurocognitive disorders
哌甲酯引发的 rTMS 治疗神经认知障碍中的冷漠
批准号：
455739
负责人：
Lanctôt Krista L
金额：
$7.29万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=455739&lang=en
关键词：
Apathy Dorsofrontal Prefrontal Cortex Methylphenidate Neurocognitive Disorder Randomized Controlled Trial Repetitive Transcranial Magnetic Stimulation

项目摘要

项目成果

Lanctôt Krista L的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Apathy is a common, early, and disabling symptom in dementias such as Alzheimer's disease (AD) and is characterized by reduced self-initiated behavior. Attempts to treat apathy include methylphenidate, a dopamine releasing agent, and repetitive transcrani
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exercise augmenting cognition tDCS (EXACT) trial: A pilot study of a combined exercise and transcranial direct current stimulation intervention for cognition
Exercise as a primer for excitatory stimulation study (EXPRESS): A combined exercise and transcranial direct current stimulation intervention for cognition
Exercise as a primer for excitatory stimulation study (EXPRESS): A combined exercise and transcranial direct current stimulation intervention for cognition
Efficacy and Safety of N-acetylcysteine (NAC) in patients with mild vascular cognitive impairment